Alpine Immune Sciences, Inc.
ALPNDelisted May 20, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001626199
Alpine Immune Sciences, Inc. was delisted on May 20, 2024; its insiders filed their last Form 4 on May 20, 2024; 180 institutions reported holding it in 13F filings for Q1 2024, worth $2.56B in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Alpine Immune Sciences, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 133 | 180 | +47 |
| Shares | 58.9M | 64.6M | +5.65M (+9.6%) |
| Value | $1.12B | $2.56B | +$1.44B (+128.0%) |
New holders (63)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (16)
Institutions that held Alpine Immune Sciences, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Ra Capital Management, L.P. | 4,909,763 | $93.6M |
| Ally Bridge Group (NY) LLC | 357,271 | $6.81M |
| StemPoint Capital LP | 246,178 | $4.69M |
| Marshall Wace, LLP | 221,118 | $4.21M |
| Hudson Bay Capital Management LP | 197,019 | $3.76M |
| Laurion Capital Management LP | 97,200 | $1.85M |
| Ghisallo Capital Management LLC | 65,000 | $1.24M |
| Jump Financial, LLC | 55,720 | $1.06M |
| Cubist Systematic Strategies, LLC | 48,670 | $927.6K |
| Walleye Trading LLC | 25,596 | $487.9K |
| Occudo Quantitative Strategies LP | 25,554 | $487.1K |
| Squarepoint Ops LLC | 21,878 | $417.0K |
| Corton Capital Inc. | 16,934 | $322.8K |
| Point72 Middle East FZE | 7,900 | $150.6K |
| AJOVista, LLC | 3,371 | $64.3K |
| ADAR1 Capital Management, LLC | 3,027 | $57.7K |